Carl Zeiss Meditec AG english

Quarterly figures within expectations

Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
-----
Quarterly figures within expectations

Q3 turnover increases by 5.1 percent --- Elimination of risks at former
Asclepion has one-off effect on results

In the first nine months of the 2001/2002 financial year (1 October 2001
to 30
June 2002) Carl Zeiss Meditec AG achieved pro forma sales revenues of EUR
172.4
million (previous year: EUR 173.6 million). The operating result (EBIT) in
this
period amounted to EUR -4.9 million (EUR 2.6 million), biased by the
one-off
elimination of risk items at the former Asclepion. In the third quarter the
Jena-based company posted a 5.1% increase in sales to EUR 57.6 million.
Due to the one-time financial burden, the pro forma result before taxes
(EBT)
totalled EUR -12.5 million (previous year: EUR 1.6 million). The after-tax
result amounted to EUR -7.6 million (previous year: EUR 1.5 million). This
corresponds to a pro forma loss per share of EUR 0.29 (previous year: EUR
0.06).
 The result reflects a EUR 15.1 million one-off adjustment for all
foreseeable
risks. This figure includes a valuation adjustment on inventories (EUR 2.6
million) and accounts receivable (EUR 3.8 million), amortisation of
goodwill of
the British subsidiary (EUR 3.4 million) not affecting liquidity and
depreciation of financial assets of the former Asclepion (EUR 5.3 million).
The pro forma figures serve to facilitate comparison with the previous
year. The
 latter is based on the premise that the new company already existed at the
start of the financial year on 1 October 2000, although the two companies
Asclepion-Meditec and Carl Zeiss Ophthalmic Systems were not merged into
Carl
Zeiss Meditec until 4 July 2002.

Contact:
Carl Zeiss Meditec AG
Jens Brajer/ Investor Relations
Göschwitzer Strasse 51-52
07745 Jena

Phone: +49 (0) 36 41 - 2 20 - 1 05
Fax: +49 (0) 36 41 - 2 20 - 1 02
E-mail: investors@meditec.zeiss.com

end of ad-hoc-announcement  (c)DGAP 16.09.2002
---------------------------------------------------------------------------
-----
WKN: 531370; ISIN: DE0005313704; Index:
Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Düsseldorf,
Hamburg,
Hannover, München und Stuttgart

160737 Sep 02